{
    "2019-03-01": [
        [
            {
                "time": "2018-01-02",
                "original_text": "Radius (RDUS) Posts Narrower Q4 Loss on Robust Tymlos Sales",
                "features": {
                    "keywords": [
                        "RDUS",
                        "Narrower",
                        "Q4",
                        "Loss",
                        "Robust",
                        "Tymlos",
                        "Sales"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "5 Pharmaceutical Stocks With Big Moats and Bridges",
                "features": {
                    "keywords": [
                        "Pharmaceutical",
                        "Stocks",
                        "Big",
                        "Moats",
                        "Bridges"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "3 Big Stock Charts for Friday: Eli Lilly, Centene and LKQ Corporation",
                "features": {
                    "keywords": [
                        "Big",
                        "Stock",
                        "Charts",
                        "Eli",
                        "Lilly",
                        "Centene",
                        "LKQ",
                        "Corporation"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "automotive"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "MTUM, JNJ, LLY, KO: ETF Inflow Alert",
                "features": {
                    "keywords": [
                        "MTUM",
                        "JNJ",
                        "LLY",
                        "KO",
                        "ETF",
                        "Inflow",
                        "Alert"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "consumer goods"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "A Look at AstraZeneca’s and Eli Lilly’s Tax and Debt",
                "features": {
                    "keywords": [
                        "AstraZeneca",
                        "Eli",
                        "Lilly",
                        "Tax",
                        "Debt"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Nektar Therapeutics (NKTR) Q4 2018 Earnings Conference Call Transcript",
                "features": {
                    "keywords": [
                        "Nektar",
                        "Therapeutics",
                        "NKTR",
                        "Q4",
                        "2018",
                        "Earnings",
                        "Conference",
                        "Call",
                        "Transcript"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Comparing AstraZeneca’s and Eli Lilly’s Dividends",
                "features": {
                    "keywords": [
                        "AstraZeneca",
                        "Eli",
                        "Lilly",
                        "Dividends"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "The Daily Biotech Pulse: Puma Biotech Earnings, Mersana Offering, Orphan Drug Designation For Ascendis",
                "features": {
                    "keywords": [
                        "Daily",
                        "Biotech",
                        "Pulse",
                        "Puma",
                        "Biotech",
                        "Earnings",
                        "Mersana",
                        "Offering",
                        "Orphan",
                        "Drug",
                        "Designation",
                        "Ascendis"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "AstraZeneca or Eli Lilly: Which Is Controlling Expenses Better?",
                "features": {
                    "keywords": [
                        "AstraZeneca",
                        "Eli",
                        "Lilly",
                        "Controlling",
                        "Expenses",
                        "Better"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Lilly to Present Data Demonstrating Continued Scientific Advancements in Broad Dermatology Portfolio at AAD Annual Meeting",
                "features": {
                    "keywords": [
                        "Lilly",
                        "Present",
                        "Data",
                        "Demonstrating",
                        "Continued",
                        "Scientific",
                        "Advancements",
                        "Broad",
                        "Dermatology",
                        "Portfolio",
                        "AAD",
                        "Annual",
                        "Meeting"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}